1. Home
  2. ULBI vs STRO Comparison

ULBI vs STRO Comparison

Compare ULBI & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ultralife Corporation

ULBI

Ultralife Corporation

HOLD

Current Price

$5.75

Market Cap

105.7M

Sector

Miscellaneous

ML Signal

HOLD

Logo Sutro Biopharma Inc.

STRO

Sutro Biopharma Inc.

HOLD

Current Price

$20.45

Market Cap

85.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ULBI
STRO
Founded
1990
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
105.7M
85.0M
IPO Year
1995
N/A

Fundamental Metrics

Financial Performance
Metric
ULBI
STRO
Price
$5.75
$20.45
Analyst Decision
Hold
Analyst Count
0
8
Target Price
N/A
$18.88
AVG Volume (30 Days)
26.5K
116.6K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
1166.67
N/A
EPS
0.09
N/A
Revenue
$164,456,000.00
N/A
Revenue This Year
$31.30
$63.08
Revenue Next Year
$6.24
N/A
P/E Ratio
$65.11
N/A
Revenue Growth
3.66
N/A
52 Week Low
$4.07
$0.52
52 Week High
$9.51
$20.59

Technical Indicators

Market Signals
Indicator
ULBI
STRO
Relative Strength Index (RSI) 37.64 73.10
Support Level $5.42 $0.76
Resistance Level $6.14 N/A
Average True Range (ATR) 0.27 1.70
MACD -0.07 0.27
Stochastic Oscillator 3.96 94.68

Price Performance

Historical Comparison
ULBI
STRO

About ULBI Ultralife Corporation

Ultralife Corp provides products and services ranging from power solutions to communications and electronics systems to customers across the globe in the government and defense, medical, safety and security, energy, and industrial sectors. The company designs, manufactures, installs, and maintains power and communications systems including rechargeable and non-rechargeable batteries, charging systems, communications and electronics systems and accessories, and custom-engineered systems. The company's segments include Battery and Energy Products, and Communications Systems. It generates maximum revenue from the Battery and Energy Products segment, and from the U.S. The Battery & Energy Products segment includes Lithium 9-volt, cylindrical, and various other non-rechargeable batteries.

About STRO Sutro Biopharma Inc.

Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.

Share on Social Networks: